Stock Events

Stock Events

Terns Pharmaceuticals (430.STU) Q1 2026 Earnings

30MarConfirmed

Q1 2026

-0.25

-0.25

-0.24

-0.24

Details

Expected EPS

-0.25124458289999996

Actual EPS

-0.2357235

Surprise EPS

0.02

Surprise Percent

+6.18%

Description

Terns Pharmaceuticals (430.STU) has reported earnings of -0.2357235 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.